| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/27/2023 | 8.7% | Stifel | → $75 | Reiterates | Buy → Buy |
| 11/14/2023 | 8.7% | UBS | $82 → $75 | Maintains | Neutral |
| 11/14/2023 | 18.84% | Barrington Research | $90 → $82 | Maintains | Outperform |
| 11/14/2023 | -5.8% | Morgan Stanley | $69 → $65 | Maintains | Underweight |
| 11/10/2023 | 1.45% | Stifel | → $70 | Upgrades | Hold → Buy |
| 11/01/2023 | 1.45% | Stifel | $80 → $70 | Maintains | Hold |
| 10/26/2023 | 21.74% | Piper Sandler | $94 → $84 | Maintains | Overweight |
| 08/09/2023 | 20.29% | JP Morgan | $80 → $83 | Maintains | Neutral |
| 08/08/2023 | 30.43% | Barrington Research | → $90 | Reiterates | Outperform → Outperform |
| 08/08/2023 | 39.13% | Credit Suisse | → $96 | Reiterates | Outperform → Outperform |
| 05/10/2023 | 30.43% | Barrington Research | $92 → $90 | Maintains | Outperform |
| 03/07/2023 | 18.84% | UBS | $75 → $82 | Maintains | Neutral |
| 02/28/2023 | 40.58% | Credit Suisse | $99 → $97 | Maintains | Outperform |
| 02/21/2023 | 0% | Morgan Stanley | $70 → $69 | Maintains | Underweight |
| 02/17/2023 | 33.33% | Barrington Research | $99 → $92 | Maintains | Outperform |
| 02/06/2023 | 40.58% | Piper Sandler | $85 → $97 | Maintains | Overweight |
| 12/21/2022 | 1.45% | Morgan Stanley | $72 → $70 | Maintains | Underweight |
| 09/26/2022 | 23.19% | Piper Sandler | $96 → $85 | Maintains | Overweight |
| 08/08/2022 | 15.94% | UBS | → $80 | Upgrades | Sell → Neutral |
| 08/03/2022 | 43.48% | Barrington Research | $102 → $99 | Maintains | Outperform |
| 08/03/2022 | 30.43% | Credit Suisse | $100 → $90 | Maintains | Outperform |
| 07/21/2022 | 23.19% | Goldman Sachs | $93 → $85 | Downgrades | Buy → Neutral |
| 06/17/2022 | 15.94% | Stifel | $90 → $80 | Maintains | Hold |
| 06/14/2022 | 27.54% | Baird | $103 → $88 | Downgrades | Outperform → Neutral |
| 05/13/2022 | 44.93% | Credit Suisse | → $100 | Assumes | → Outperform |
| 02/16/2022 | 4.35% | Morgan Stanley | $67 → $72 | Maintains | Underweight |
| 02/16/2022 | 44.93% | Credit Suisse | $90 → $100 | Maintains | Outperform |
| 01/31/2022 | -2.9% | Morgan Stanley | → $67 | Initiates Coverage On | → Underweight |
| 01/07/2022 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 02/08/2021 | 20.29% | Piper Sandler | → $83 | Assumes | → Overweight |
| 01/04/2021 | 14.49% | Baird | $70 → $79 | Upgrades | Neutral → Outperform |
| 05/07/2020 | -27.54% | UBS | $60 → $50 | Maintains | Sell |
| 05/06/2020 | -13.04% | Baird | $58 → $60 | Maintains | Neutral |
| 05/05/2020 | -13.04% | CFRA | $69 → $60 | Maintains | Hold |
| 04/02/2020 | -1.45% | Wolfe Research | → $68 | Upgrades | Peer Perform → Outperform |
| 03/31/2020 | -17.39% | Barclays | $58 → $57 | Maintains | Equal-Weight |
| 02/24/2020 | -1.45% | JP Morgan | $66 → $68 | Maintains | Neutral |
| 01/02/2020 | 1.45% | Evercore ISI Group | $61 → $70 | Upgrades | Underperform → In-Line |
| 12/03/2019 | 2.9% | B of A Securities | $69 → $71 | Maintains | Neutral |
| 11/12/2019 | -18.84% | UBS | $57 → $56 | Maintains | Sell |
| 08/07/2019 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 05/15/2019 | 1.45% | SVB Leerink | $75 → $70 | Downgrades | Outperform → Market Perform |
| 04/18/2019 | 4.35% | Guggenheim | → $72 | Initiates Coverage On | → Buy |
| 02/21/2019 | -8.7% | Barclays | $73 → $63 | Maintains | Equal-Weight |
| 01/17/2019 | 5.8% | UBS | → $73 | Initiates Coverage On | → Sell |
| 01/03/2019 | — | Evercore ISI Group | Downgrades | In-Line → Underperform | |
| 01/02/2019 | — | Baird | Downgrades | Outperform → Neutral |
What is the target price for Henry Schein (HSIC)?
The latest price target for Henry Schein (NASDAQ: HSIC) was reported by Stifel on November 27, 2023. The analyst firm set a price target for $75.00 expecting HSIC to rise to within 12 months (a possible 8.70% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Henry Schein (HSIC)?
The latest analyst rating for Henry Schein (NASDAQ: HSIC) was provided by Stifel, and Henry Schein reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Henry Schein (HSIC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Henry Schein, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Henry Schein was filed on November 27, 2023 so you should expect the next rating to be made available sometime around November 27, 2024.
Is the Analyst Rating Henry Schein (HSIC) correct?
While ratings are subjective and will change, the latest Henry Schein (HSIC) rating was a reiterated with a price target of $0.00 to $75.00. The current price Henry Schein (HSIC) is trading at is $69.00, which is within the analyst's predicted range.